Atlas Trials

Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia

Clinical trial NCT04951362 · UNKNOWN

Trial details

NCT number
NCT04951362
Sponsor
South Valley University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Anosmia
Start date
2021-04-20
Primary completion
2022-05-12
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.